Ligand Pharmaceuticals | LGND - Lieferungen Und Leistungen





Lieferungen Und Leistungen Veränderung Datum
Agenus USD 71.08M 11.9M 2026-03
Amgen USD 19.52B 1.37B 2026-03
Anika Therapeutics USD 6.34M 298K 2026-03
Arrowhead Research USD 30.75M 2.19M 2026-03
Baxter International USD 1.09B 87M 2026-03
Bristol-Myers Squibb USD 4.23B 659M 2026-03
Eli Lilly USD 5.03B 350M 2026-03
Enanta Pharmaceuticals USD 1.88M 63K 2025-12
Enviri Corporation USD 257.33M 17.68M 2026-03
Gilead Sciences USD 645M 70M 2026-03
GlaxoSmithKline GBP 14.34B 1.05B 2026-03
Glaxosmithkline GBP 20.72B 346.14M 2025-12
Heron Therapeutics USD 8.97M 24K 2026-03
Insmed USD 73.38M 6.53M 2026-03
Intrexon USD 4.85M 3.12M 2024-06
Ionis Pharmaceuticals USD 26.03M 2.05M 2026-03
Karyopharm Therapeutics USD 4M 1.39M 2025-12
Ligand Pharmaceuticals USD 37.11M 33.87M 2026-03
MacroGenics USD 4.29M 500K 2026-03
Merck USD 3.86B 541M 2026-03
Pacira USD 14.01M 1.14M 2026-03
Pfizer USD 4.51B 734M 2026-03
Rigel Pharmaceuticals USD 3.85M 3.44M 2025-09
Sangamo BioSciences USD 10.74M 7.46M 2025-06
Veracyte USD 6.91M 2.32M 2026-03